Risk of acute infections in patients with psoriasis: A nationwide population-based cohort study - 11/02/20
Doi : 10.1016/j.jaad.2019.10.072
Bo Ri Kim, MD a, Danbee Kang, PhD b, c, Minwoong Kang, MS c, Sungkeun Shim, MS c, Chang Kyung Kang, MD d, Dong Wook Kim, PhD e, Eliseo Guallar, MD, DrPH b, c, f, Juhee Cho, PhD b, c, f, ⁎ 
, Sang Woong Youn, MD, PhD a, ⁎
, Sang Woong Youn, MD, PhD a, ⁎ a Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
b Department of Clinical Research Design and Evaluation, The Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, Korea
c Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
d Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Hospital, Korea
e Department of Policy Research Affairs, National Health Insurance Service Ilsan Hospital
f Department of Epidemiology, and Welch Center for Epidemiology, Prevention, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore
∗Correspondence to: Juhee Cho, PhD, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, 2024 E Monument St, Baltimore, MDDepartment of EpidemiologyJohns Hopkins Bloomberg School of Public Health, Baltimore2024 E Monument StBaltimoreMD∗Sang Woong Youn, MD, PhD, Department of Dermatology, Seoul National University Bundang Hospital, 82 Gumi-Ro 173 Beon-Gil, Seongnam, Gyeonggi 13620, KoreaDepartment of DermatologySeoul National University Bundang Hospital82 Gumi-Ro 173 Beon-GilSeongnamGyeonggi13620Korea
| Drs Kim and Kang are cofirst authors. |
|
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: The Institutional Review Board of the Samsung Medical Center approved this study (IRB number SMC 2018-02-137). |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 3
P. 764-766 - mars 2020 Retour au numéro
Article précédent
- Cost and utilization of immunotherapy and targeted therapy for melanoma: Cross-sectional analysis in the Medicare population, 2013 and 2015
- Kira Seiger, Chrysalyne D. Schmults, Ann W. Silk, Emily Stamell Ruiz
- Assessing perceived adverse effects of biologic medications for patients with psoriasis
- Jeremy K. Bray, Abigail Cline, Steven R. Feldman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?